Type IV endoleak is a very rare complication observed after implantation of aortobiiliac stent grafts. The difficult diagnosis of type IV endoleak leads to the application of many imaging methods in ...

The lack of any presence of endoleak at the initial imaging after endovascular aortic aneurysm repair (EVAR) is predictive of good midterm outcomes with less need for reintervention. As such, patients ...

Thoracic endovascular aortic repair (TEVAR) effectively improved the results of thoracic aortic aneurysm treatment. TEVAR is a less invasive procedure that can be performed under local anesthesia with ...

For the second time this year, the US Food and Drug Administration has issued a safety communication to healthcare professionals regarding risk of Type III endoleaks associated with Endologix AFX ...

A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...

Please provide your email address to receive an email when new articles are posted on . The FDA’s Circulatory System Devices Panel advised that for a stent graft system to treat patients with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio New data from the EVAS FORWARD Global ...